CRISPR/Cas9-mediated genomic deletion of the beta-1, 4 nacetylgalactosaminyltransferase 1 gene in murine P19 embryonal carcinoma cells results in low sensitivity to botulinum neurotoxin type C

Kentaro Tsukamoto, Chikako Ozeki, Tomoko Kohda, Takao Tsuji

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CRISPR/Cas9-mediated genomic deletion of the beta-1, 4 nacetylgalactosaminyltransferase 1 gene in murine P19 embryonal carcinoma cells results in low sensitivity to botulinum neurotoxin type C'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology

Chemical Compounds